Summary of all studies containing PUBCHEM ID 5283569
| Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
|---|---|---|---|---|---|
| PR001285 | ST002023 | A targeted metabolomics study for assessing rodent thyroid toxicity | Mammal | Rattus norvegicus | Ceramides__Cer(d18:1/26:1) [Data] |
| PR002249 | ST003694 | FOLFIRINOX effects on lipidomics in pancreatic cancer cells | Cultured cells | Homo sapiens | Cer(d18:1/26:1) [Data] |
| PR000480 | ST000679 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part II | Human | Homo sapiens | N-(17Z-hexacosenoyl)-sphing-4-enine; [M-H]-@8.92 [Data] |
| PR000045 | ST000047 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Human | Homo sapiens | Ceramide(d18:1/26:1(17Z)) [Data] |
| PR001935 | ST003114 | Lipidomics analyses in model membranes, isolated mitochondria and cellular systems to study how the local lipid environment affects BAX and BAK function during apoptosis. | Cultured cells | Homo sapiens | Cer 18:1;O2/26:1 [Data] |
| PR000004 | ST000004 | Lipidomics studies on NIDDK / NIST human plasma samples | Human | Homo sapiens | Cer(d18:1/26:1) [Data] |
| PR002249 | ST003637 | lomitapide effects on lipidomics | Cultured cells | Homo sapiens | Cer(d18:1/26:1) [Data] |
| PR001737 | ST002787 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Human | Homo sapiens | Cer(d18:1/26:1) [Data] |
| PR000121 | ST000136 | NIST lipidomics intralaboratory study | Human | Homo sapiens | Cer 26:1 [Data] |
| PR000004 | ST000005 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Animal | Mus musculus | C26:1 Cer [Data] |
